STAR Protocols (Jun 2021)

Selective immunocapture and light-controlled traceless release of transiently caged proteins

  • Rasa Rakauskaitė,
  • Giedrė Urbanavičiūtė,
  • Martynas Simanavičius,
  • Aurelija Žvirblienė,
  • Saulius Klimašauskas

Journal volume & issue
Vol. 2, no. 2
p. 100455

Abstract

Read online

Summary: The 4,5-dimethoxy-2-nitrobenzyl (DMNB) photocaging group introduced into small biomolecules, peptides, oligonucleotides, and proteins is commonly used for spatiotemporal control of chemical and biological processes. Here, we describe the use of a DMNB-selective monoclonal antibody for non-covalent capture of chemically or biosynthetically produced proteins containing surface-exposed DMNB caging groups followed by light-controlled traceless decaging and release of the bound proteins into solution for a variety of downstream applications.For complete details on the use and execution of this protocol, please refer to Rakauskaitė et al. (2020).

Keywords